logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Anti-D-Dimer antibody
Mouse anti-human, monoclonal IgG1
D-dimer is a small protein fragment, or fibrin degradation product (FDP), present in blood after a blood clot has been degraded by fibrinolysis. It is composed of two D fragments of the fibrin protein joined together by a cross-link. Elevated d-dimer levels are a key indicator or thrombotic events, indicating excess fibrinolysis, following activation of coagulation. In clinical biology, it is used in the diagnosis of the blood disorder disseminated intravascular coagulation. Anti-D-Dimer monoclonal antibodies are highly sensitive for the detection of human D-dimer immunogens. They can be used in a broad range of immunoassays such as lateral-flow immunoassays (LFIA) and in IVD assay development.
<p>Comparison between D-Dimer LFIA and diagnostic kit: 50 samples from donors were quantitatively tested using AAT Bioquest&rsquo;s anti-D-Dimer antibodies in LFIA for the detection of D-dimer and a comparison kit. Results showed good correlation between both immunoassays, and the sensitivity reached to 0.2&mu;g/ml.</p>
<p>Comparison between D-Dimer LFIA and diagnostic kit: 50 samples from donors were quantitatively tested using AAT Bioquest&rsquo;s anti-D-Dimer antibodies in LFIA for the detection of D-dimer and a comparison kit. Results showed good correlation between both immunoassays, and the sensitivity reached to 0.2&mu;g/ml.</p>
CatalogSize
Price
Quantity
V10011050 ug
Price
V1001111 mg
Price
 
Physical properties

SolventWater
Antibody properties

Hostmouse
Reactivityhuman
ApplicationELISA; LFIA; LETIA
Storage, safety and handling

Intended useResearch Use Only (RUO)
StorageFreeze (< -15 °C)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 13, 2025